Research by David Dietz, PhD, has the potential to identify novel therapies to treat addiction to cocaine and other psychostimulants, for which no effective drug therapy exists.
Wilma A. Hofmann, PhD, assistant professor of physiology and biophysics, will study cellular processes that cause high levels of unsaturated fats to increase the metastatic potential of prostate cancer cells.
University at Buffalo researchers are part of an international team developing a novel imaging technique with nanoparticles suspended in liquid to provide an unparalleled, noninvasive, real-time view of the small intestine.
Anthony L. Auerbach, PhD, professor of physiology and biophysics, will further develop ‘energy maps’ detailing the microscopic changes that occur as neurotransmitters activate protein receptors in a cell’s membrane.
Zhen Yan, PhD, professor of physiology and biophysics, has received $1.6 million to continue her study of human dopamine D4 receptor variants — a type of neurotransmitter receptor in the brain’s prefrontal cortex.
A novel compound severely blunts a host of cocaine addiction behaviors, including relapse behavior, according to a University at Buffalo animal study that holds promise for a groundbreaking treatment.
Using tiny modified liposomes, University at Buffalo researchers are developing a chemotherapy delivery method that could improve cancer treatment, reduce its side effects and boost knowledge about the disease.
M. Laura Feltri, MD, professor of biochemistry and neurology, and a member of the Hunter James Kelly Research Institute (HJKRI), will explore the role of integrins and RhoGTPAses in the cellular communication processes that lead to myelination in peripheral nerves.
Novel research by a University at Buffalo scientist demonstrates a causal relationship between the release of dopamine in the brain and drinking behaviors of animals.
Ira Jacob Blader, PhD, associate professor of microbiology and immunology, will build on prior research to identify and explore a key host cell pathway essential for the growth of the infection-causing parasite Toxoplasma gondii.
University at Buffalo experiments from a day care center have revealed that two common bacteria persist on various surfaces for extended periods of time.
To advance promising research on schizophrenia, the Patrick P. Lee Foundation will fund long-term fellowships for three advanced research trainees in the lab of Michal K. Stachowiak, PhD, professor of pathology and anatomical sciences.
With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.
Applicants are required to apply to the PhD Program in Biomedical Sciences through Graduate School Application Manager, UB's electronic application system.
